Catalent
CTLT
#1737
Rank
C$15.91 B
Marketcap
C$87.70
Share price
0.00%
Change (1 day)
12.11%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$8.51 Billion

According to Catalent's latest financial reports the company's total liabilities are C$8.51 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30C$8.16 B10.57%
2022-06-30C$7.38 B23.1%
2021-06-30C$5.99 B3.42%
2020-06-30C$5.79 B13.68%
2019-06-30C$5.09 B12.6%
2018-06-30C$4.52 B27.67%
2017-06-30C$3.54 B11.5%
2016-06-30C$3.18 B1.82%
2015-06-30C$3.12 B-15.42%
2014-06-30C$3.69 B4.59%
2013-06-30C$3.53 B-0.59%
2012-06-30C$3.55 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Supernus Pharmaceuticals
SUPN
C$0.51 B-94.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.74 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C$10.21 B 19.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
C$0.44 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA